Biotechnology

Techseriesinsight > Blog > News > Biotechnology

March 19, 2025
PRNewswire
Biotechnology

Whole Foods sells scarred Frankenchicken meat with evidence of muscle abnormality, Mercy For Animals report shows

Mercy For Animals’ new shopper-led report, “White Striping at Whole Foods,” spotlights the use of fast-growing chicken breeds, referred to as “Frankenchickens,” in Whole Foods’ supply chain. Despite the...

March 18, 2025
PRNewswire
Biotechnology

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational...

March 13, 2025
PRNewswire
Biotechnology

Registration Now Open for World Vaccine Congress Washington 2025: Leading Experts from Government, WHO, CEPI, and more to Speak

The World Vaccine Congress Washington 2025, the largest and most influential global vaccine event, is officially open for registration. Taking place from April 21-24, 2025, at the Walter E....

March 12, 2025
PRNewswire
Biotechnology

Vivace Therapeutics Raises $35 Million in Series D Financing to Support Clinical Development of First-in-Class Cancer Drug Targeting the Hippo Pathway

Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway, today announced the closing of a $35 million Series D financing. The round...

March 11, 2025
PRNewswire
Biotechnology

Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025

Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, is highlighting its latest advancements in digital orthopaedics at the American Academy of Orthopaedic Surgeons (AAOS) 2025...

January 2, 2025
PRNewswire
Biotechnology

FDA Grants Orphan Drug Designation to MicuRx’s MRX-5 for NTM Infections

Shanghai MicuRx Pharmaceutical Co., Ltd. (“MicuRx”，688373.SH) announced that MRX-5, its self-developed anti-infection drug, has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for...

January 2, 2025
PRNewswire
Biotechnology

WuXi Biologics Ranks Top in 2024 Dow Jones Sustainability Indices for Second Consecutive Year

WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has been named to the 2024 Dow Jones Sustainability Indices...

January 2, 2025
PRNewswire
Biotechnology

Veeda Group Rebrands as ‘Veeda Lifesciences’

Veeda Group has unveiled a new logo and brand identity—Veeda Lifesciences—marking a key milestone in its journey. The new brand name reflects the evolution from a generics-focused Contract Research...

January 2, 2025
PRNewswire
Biotechnology

Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers

Fapon Biopharma, an innovator in developing therapeutic antibodies and fusion proteins, will present its latest breakthrough immunocytokine, FP008, on Jan 14, 2025, at the Biotech Showcase investor conference, following J.P....

December 24, 2024
Business Wire
Biotechnology

Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients...